BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 10083249)

  • 1. Prolonged small bowel allograft survival following repeated intrathymic injections of donor splenocytes and peripheral anti-lymphocyte treatment.
    Sun S; Greenstein SM; Schechner RS; Tellis VA
    Transplant Proc; 1999; 31(1-2):588-9. PubMed ID: 10083249
    [No Abstract]   [Full Text] [Related]  

  • 2. Donor intrathymic injection with recipient splenocytes allows indefinite survival following small bowel transplantation in a rat graft-vs-host disease model.
    Blakely ML; Shaffer D; Ohzato H; Gottschalk R; Van der Werf WJ; Monaco AP
    Transplant Proc; 1994 Jun; 26(3):1582. PubMed ID: 8030046
    [No Abstract]   [Full Text] [Related]  

  • 3. A second intrathymic injection of donor splenocytes improves survival of small bowel allografts.
    Sun S; Greenstein SM; Kim DY; Schreiber TC; Schechner RS; Tellis VA
    Transplant Proc; 1998 Sep; 30(6):2575-6. PubMed ID: 9745495
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunomodulation with intrathymic injection of donor splenocytes followed by CTLA4Ig therapy prolongs small intestinal allograft survival.
    Greenstein SM; Sun S; Schechner RS; Tellis VA
    Transplant Proc; 1997; 29(1-2):1065-6. PubMed ID: 9123201
    [No Abstract]   [Full Text] [Related]  

  • 5. Intrathymic injection of allogeneic cells induces indefinite survival of cardiac but not small bowel grafts.
    Xia W; Sayegh MH; Kirkman RL
    Transplant Proc; 1994 Jun; 26(3):1581. PubMed ID: 8030045
    [No Abstract]   [Full Text] [Related]  

  • 6. Tolerance for graft-versus-host disease by intrathymic injection of recipient-type splenocytes into donor.
    Vaidya S; Wang CC; Roorda C; Billings A; Rajaraman S; Fish JC
    Transplant Proc; 1997; 29(1-2):1073-5. PubMed ID: 9123205
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of intrathymic injection of donor splenocytes on rat small bowel allograft survival.
    Karim MS; Webster GA; Wood RF; Pockley AG
    Transplant Proc; 1994 Jun; 26(3):1583-4. PubMed ID: 8030047
    [No Abstract]   [Full Text] [Related]  

  • 8. Generation of suppressor cells maintains donor-specific tolerance after intrathymic injection of alloantigen.
    Nakafusa Y; Arima T; Goss JA; Flye MW
    Transplant Proc; 1995 Feb; 27(1):128-9. PubMed ID: 7878881
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of simultaneous intrathymic injection of two unrelated cellular alloantigens on rat cardiac allograft survival.
    Shimomura K; Hardy MA; Oluwole SF
    Transplant Proc; 1995 Feb; 27(1):127. PubMed ID: 7878878
    [No Abstract]   [Full Text] [Related]  

  • 10. Indefinite survival following small intestinal transplantation after intrathymic injection of the donor with recipient-type splenocytes in a rat model.
    Blakely ML; Shaffer D; Ohzato H; Gottschalk R; Van der Werf WJ; Monaco AP
    Transplantation; 1995 Jan; 59(2):309-11. PubMed ID: 7839457
    [No Abstract]   [Full Text] [Related]  

  • 11. Prolonged survival of rat cardiac allografts after intrathymic inoculation of donor thymocytes.
    Odorico JS; Barker CF; Markmann JF; Posselt AM; Naji A
    Transplant Proc; 1993 Feb; 25(1 Pt 1):295-6. PubMed ID: 8438306
    [No Abstract]   [Full Text] [Related]  

  • 12. Organ-specific tolerance induced by intrathymic injection of donor bone marrow cells and FK 506 or antilymphocyte serum in rat heart transplantation.
    Matsuura T; Imanishi M; Hara Y; Tahara H; Kanda H; Kurita T
    Transplant Proc; 1994 Aug; 26(4):1962-3. PubMed ID: 7520616
    [No Abstract]   [Full Text] [Related]  

  • 13. Intraportal injection of specific allogeneic cells can prolong neonatal intestinal free graft survival.
    Lee SK; Perez-Atayde A; Takeda T; Vacanti JP; Lund DP
    Transplant Proc; 1994 Jun; 26(3):1579-80. PubMed ID: 8030044
    [No Abstract]   [Full Text] [Related]  

  • 14. Intraportal donor-specific transfusion given 24 hours before small bowel transplantation with cyclosporine and FK 506.
    Takara T; Tchervenkov JI; Guttman FM; Fecteau A; Rosenmann E
    Transplant Proc; 1994 Jun; 26(3):1622. PubMed ID: 7518150
    [No Abstract]   [Full Text] [Related]  

  • 15. Induction of tolerance to an "untolerizable" strain by double-strain intrathymic inoculation in experimental rat cardiac transplantation.
    Mohiuddin MM; Yokoyama H; Reiss GR; DiSesa VJ
    Transplant Proc; 1999; 31(1-2):838-9. PubMed ID: 10083364
    [No Abstract]   [Full Text] [Related]  

  • 16. Skin allograft survival following intrathymic injection of donor bone marrow.
    Cober SR; Randolph MA; Lee WP
    J Surg Res; 1999 Aug; 85(2):204-8. PubMed ID: 10423320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tolerance to cardiac allografts requires a time lag between intrathymic treatment and transplantation.
    Goldstein C; Reiss GR; Mohiuddin M; Shen Z; Yokoyama H; DiSesa VJ
    J Surg Res; 1996 Jun; 63(1):83-5. PubMed ID: 8661177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lethal graft-vs-host disease after cyclosporine therapy in recipients of sensitized small bowel allografts.
    Langrehr JM; Markus PM; Lee TK; Müller AR; Banner B; Lee KK; Schraut WH
    Transplant Proc; 1992 Jun; 24(3):1138. PubMed ID: 1604556
    [No Abstract]   [Full Text] [Related]  

  • 19. Intrathymic spleen cell inoculation and ALS fails to induce tolerance to rat pancreas allografts.
    Schulak JA; Mulligan DC; Robinson A
    Transplant Proc; 1997; 29(1-2):1070-1. PubMed ID: 9123203
    [No Abstract]   [Full Text] [Related]  

  • 20. MHC class II presenting cells are necessary for the induction of intrathymic tolerance.
    Goss JA; Nakafusa Y; Flye MW
    Ann Surg; 1993 May; 217(5):492-9; discussion 499-501. PubMed ID: 8489312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.